Jacobio Pharmaceuticals Group Co., Ltd. (OTCMKTS:JBPHF – Get Free Report) was the recipient of a large growth in short interest in the month of May. As of May 29th, there was short interest totaling 900 shares, a growth of ∞ from the May 14th total of 0 shares. Based on an average trading volume of 0 shares, the short-interest ratio is currently ∞ days.
Jacobio Pharmaceuticals Group Stock Performance
OTCMKTS:JBPHF opened at $0.87 on Friday. Jacobio Pharmaceuticals Group has a 52 week low of $0.73 and a 52 week high of $1.10. The stock’s 50-day moving average price is $0.87 and its 200-day moving average price is $0.86.
Jacobio Pharmaceuticals Group Company Profile
Jacobio Pharmaceuticals Group Co, Ltd. is a clinical‐stage biopharmaceutical company headquartered in Tianjin, China, specializing in the discovery and development of small‐molecule therapeutics for oncology. The company’s research platform is built around targeted kinase inhibitors and epigenetic modulators aimed at addressing acute leukemias and select solid tumors with high unmet medical need.
Jacobio’s pipeline comprises multiple preclinical and clinical‐stage programs focused on genetically defined cancers, including agents designed to inhibit mutant FLT3, menin‐MLL interactions and other oncogenic drivers.
Read More
- Five stocks we like better than Jacobio Pharmaceuticals Group
- Time to Sell? 3 Winners With Fading Technical Momentum
- Why These 2 Hotel Stocks Are Beating Travel Peers
- This Energy Stock Has Quietly Soared 130% in a Year
- 3 ‘Boring’ Dividend Stocks With Tasty Technical Setups
Receive News & Ratings for Jacobio Pharmaceuticals Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jacobio Pharmaceuticals Group and related companies with MarketBeat.com's FREE daily email newsletter.
